PrintBio joined the ARPA-H PRINT Program, contributing 3D-bioprinting expertise to a kidney-bioprinting initiative.
PrintBio is a clinical- and commercial-stage biotechnology company and leader in regenerative medicine using novel 3D-bioprinting and material science technologies to deliver safe, functional and personalized products, and living tissues and organs, engineered and produced on-demand for patients
PrintBio is a clinical- and commercial-stage biotechnology company and leader in regenerative medicine using novel 3D-bioprinting and material science technologies to deliver safe, functional and personalized products, and living tissues and organs, engineered and produced on-demand for patients.